Target intelligence / Profile preview

Upper airway dilator muscle

Molecular classification
Other (skeletal muscle group, not a single molecular entity; not an enzyme, receptor, transporter, etc.)
01

Overview

The upper airway dilator muscles are a group of skeletal muscles in the pharyngeal and oral region—including the genioglossus (the most important member), levator palatini, tensor palatini, geniohyoid, and stylopharyngeus—which contract to maintain airway openness, particularly during inspiration[2][3][6][7]. These muscles are vital for preventing airway collapse, especially during sleep, and are critically involved in the pathophysiology of obstructive sleep apnea when their activity is diminished[2][3][5][7]. Their contraction is coordinated via neural reflexes that respond rapidly to negative airway pressure, with the genioglossus muscle innervated primarily by the hypoglossal nerve[1][3]. While the upper airway dilator muscles are essential in respiratory physiology and sleep medicine, they do not represent a classical drug target such as a receptor or enzyme, being instead a functional and anatomical category[3][4][7].

Other names
Upper airway musclespharyngeal dilator musclesUA dilators
02

Mechanism of action

Not applicable (these are anatomical and physiological structures, not molecular targets; interventions aim to increase muscle tone via neural or device-based approaches rather than direct "molecule-receptor" mechanisms)

03

Biological functions

Airway patency maintenanceReflexive airway dilation in response to negative inspiratory pressureModulation of airway resistance, especially during sleep
04

Disease associations

Obstructive sleep apnea (OSA)Sleep disordered breathingUpper airway collapsibility
05

Safety considerations

Weakness of these muscles (e.g., due to sedatives, neuromuscular blockade, sleep) leads to airway collapseAdverse events associated with interventions to enhance their function (such as hypoglossal nerve stimulators) may include device complications
06

Interacting drugs

None directly specific to "upper airway dilator muscles" as a group. Some drugs may indirectly affect their function by altering neural control (e.g., central nervous system depressants exacerbate OSA by reducing tone, but these are not direct binders/ligands to a canonical target)
07

Biomarkers

Electromyography (EMG) activity of genioglossus or other dilator muscles for physiological studiesUpper airway resistance (Rphar) and critical closing pressure (Pcrit)

Beyond the preview

Go deeper on Upper airway dilator muscle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Upper airway dilator muscle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call